This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
DowDuPont Agriculture Unit, Monsanto Land Insect Control Deal
by Zacks Equity Research
DowDuPont's (DWDP) agricultural unit and Monsanto will develop a next generation insect control technology to resist crop damage in United States and Canada.
Monsanto (MON) Up 6% Since Earnings Report: Can it Continue?
by Zacks Equity Research
Monsanto (MON) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Bayer (BAYRY) Misses Earnings and Revenue Estimates in Q1
by Zacks Equity Research
Bayer (BAYRY) misses first-quarter 2018 earnings and sales estimates.
Bayer to Divest 3.6% Stake to Singapore Company Temasek
by Zacks Equity Research
Bayer (BAYRY) will divest its 3.6% stake to Singapore's state investment company Temasek for total gross proceeds of ???3 billion.
Monsanto Company (MON) Surges: Stock Moves 6.2% Higher
by Zacks Equity Research
Monsanto (MON) was a big mover last session, as the company saw its shares rise more than 6% on the day amid huge volumes.
Monsanto (MON) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Monsanto Company (MON) reported weaker-than-expected second-quarter fiscal 2018 results.
Zacks Industry Outlook Highlights: DowDuPont, Albemarle and Monsanto
by Zacks Equity Research
Zacks Industry Outlook Highlights: DowDuPont, Albemarle and Monsanto
Andersons (ANDE) Rides on Strategic Objectives & Tax Reform
by Zacks Equity Research
Andersons (ANDE) anticipated to gain from the company's focus on strategic objectives and the U.S. tax reform.
Monsanto (MON) Q1 Earnings Top, Revenues Miss Estimates
by Zacks Equity Research
Monsanto Company (MON) reported mixed first-quarter fiscal 2018 results.
Monsanto (MON) Premium Herbicide Declared Non-Carcinogenic
by Zacks Equity Research
The National Cancer Institute recently announced that Monsanto Company's (MON) Roundup herbicide is non-cancerous.
Chemical Industry on Solid Footing: Stocks Worth a Look
by Zacks Equity Research
The industry's upturn is expected to continue on sustained momentum across major end-markets.
Bunge (BG) Jumps: Stock Rises 6.8%
by Zacks Equity Research
Bunge Limited (BG) saw its shares rise nearly 7% on the day
Why Monsanto (MON) Could Beat Earnings Estimates Again
by Zacks Equity Research
Monsanto (MON) boasts a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
Monsanto (MON) Beats on Q4 Fiscal 2017 Earnings & Revenues
by Zacks Equity Research
Monsanto Company (MON) reported better-than-expected fourth-quarter fiscal 2017 results.
Top Stock Reports for Starbucks, Medtronic & Monsanto
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Starbucks (SBUX), Medtronic (MDT) and Monsanto (MON).
Will Oil Price Volatility Affect These Agriculture Stocks?
by Zacks Equity Research
Hike in crude oil price raises cost of producing agricultural products and results in higher food prices and vice versa. Also, use of biofuel will boost demand for feedstock like corn and sugar.
Chemical Industry in Fine Shape: Stocks to Bet on Right Now
by Zacks Equity Research
Despite a few industry-related headwinds -- weak demand across agricultural and energy markets and sluggishness in China -- there are a number of reasons to be optimistic about the broader chemical industry for both the short and long haul.
Monsanto (MON) Slips to Hold, Currency & Pricing Woes Linger
by Zacks Equity Research
On Jul 3, Monsanto Company (MON) was downgraded to a Zacks Rank #3 (Hold) from a Zacks Rank #2 (Buy).
Top Analyst Reports for Disney, Charter Communications & Monsanto
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Disney (DIS), Charter Communications (CHTR), and Monsanto (MON).
What you need to know about Modi's India?
by John Blank
The Nation of India Catches My Eye.
Ransomware, Fed And Oil In Focus
by Zacks Equity Research
Ransomware, Fed And Oil In Focus
Monsanto (MON) Tops Q3 Earnings, Confirms FY17 EPS View
by Zacks Equity Research
Monsanto Company (MON) reported better-than-expected results for third-quarter fiscal 2017 (ended May 31, 2017).
Monsanto (MON) Beats on Q3 Fiscal 2017 Earnings & Revenues
by Zacks Equity Research
Monsanto Company (MON) reported better-than-expected third-quarter fiscal 2017 results.
The Zacks Analyst Blog Highlights: Caterpillar, Intel, Monsanto, General Motors and Raytheon
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Caterpillar, Intel, Monsanto, General Motors and Raytheon
Top Analyst Reports for Caterpillar, Intel & Monsanto
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Caterpillar (CAT), Intel (INTC) and Monsanto (MON).